The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Simultaneous comparison with changes in the normal myocardium.
D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D001565:Benzoates / Q000008:administration & dosage; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D005260:Female; D006863:Hydrogen-Ion Concentration; D007022:Hypotension / Q000503:physiopathology; D008026:Ligation; D008297:Male; D009203:Myocardial Infarction / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D011868:Radioisotopes; D014665:Vasodilator Agents / Q000494:pharmacology*; D014978:Xenon
D001381:Azepines; D001565:Benzoates; D011868:Radioisotopes; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D014978:Xenon